🔎 Trials Near Me

Hem › Lupusnefrit › Colorado

Kliniska studier för Lupusnefrit i Colorado

7 studier för Lupusnefrit söker deltagare vid platser i Colorado.

Städer i Colorado

Officiell studietext (engelska)

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

  • University of Colorado Denver, Aurora
RekryterarFas 2
Ålder 18 till 100 · Alla kön · Uppdaterad 1 okt. 2026 · NCT05268289

VIBRANT: VIB4920 for Active Lupus Nephritis

  • University of Colorado School of Medicine: Division of Rheumatology, Aurora
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 16 sep. 2026 · NCT05201469

The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study

  • Children's Hospital Colorado, Aurora
RekryterarFas 2
Ålder 8 till 20 · Alla kön · Uppdaterad 14 sep. 2026 · NCT05538208

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

  • University of Colorado Denver, Aurora
RekryterarFas 1
Ålder 18 till 74 · Alla kön · Uppdaterad 10 sep. 2026 · NCT07085104

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants

  • Children's Hospital Colorado, Anchutz Medical Campus, Aurora
RekryterarFas 2
Ålder 5 till 17 · Alla kön · Uppdaterad 3 sep. 2026 · NCT05039619

PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

  • Western Nephrology & Metabolic Bone Disease, PC, Arvada
RekryterarFas 4
Ålder 18 till 75 · Alla kön · Uppdaterad 3 aug. 2026 · NCT07611214

A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101

  • University of Colorado, Denver, Denver
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 11 feb. 2026 · NCT07403188

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.